Timothy E Sweeney1,2, Tej D Azad1,2, Michele Donato1,2, Winston A Haynes1,2, Thanneer M Perumal3, Ricardo Henao4,5, Jesús F Bermejo-Martin6, Raquel Almansa6, Eduardo Tamayo6, Judith A Howrylak7, Augustine Choi8, Grant P Parnell9, Benjamin Tang, Marshall Nichols4, Christopher W Woods4,10,11, Geoffrey S Ginsburg4, Stephen F Kingsmore12, Larsson Omberg3, Lara M Mangravite3, Hector R Wong13,14, Ephraim L Tsalik4,10,11, Raymond J Langley15, Purvesh Khatri1,2. 1. Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA. 2. Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA. 3. Sage Bionetworks, Seattle, WA. 4. Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC. 5. Department of Electrical and Computer Engineering, Duke University, Durham, NC. 6. Bio Sepsis, Hospital Clínico Universitario de Valladolid/IECSCYL, Valladolid, Spain. 7. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA. 8. Department of Medicine, Cornell Medical Center, New York, NY. 9. Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Sydney, NSW, Australia. 10. Division of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, NC. 11. Durham Veteran's Affairs Health Care System, Durham, NC. 12. Rady Children's Institute for Genomic Medicine, San Diego, CA. 13. Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, Cincinnati, OH. 14. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH. 15. Department of Pharmacology, University of South Alabama, Mobile, AL.
Abstract
OBJECTIVES: To find and validate generalizable sepsis subtypes using data-driven clustering. DESIGN: We used advanced informatics techniques to pool data from 14 bacterial sepsis transcriptomic datasets from eight different countries (n = 700). SETTING: Retrospective analysis. SUBJECTS: Persons admitted to the hospital with bacterial sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A unified clustering analysis across 14 discovery datasets revealed three subtypes, which, based on functional analysis, we termed "Inflammopathic, Adaptive, and Coagulopathic." We then validated these subtypes in nine independent datasets from five different countries (n = 600). In both discovery and validation data, the Adaptive subtype is associated with a lower clinical severity and lower mortality rate, and the Coagulopathic subtype is associated with higher mortality and clinical coagulopathy. Further, these clusters are statistically associated with clusters derived by others in independent single sepsis cohorts. CONCLUSIONS: The three sepsis subtypes may represent a unifying framework for understanding the molecular heterogeneity of the sepsis syndrome. Further study could potentially enable a precision medicine approach of matching novel immunomodulatory therapies with septic patients most likely to benefit.
OBJECTIVES: To find and validate generalizable sepsis subtypes using data-driven clustering. DESIGN: We used advanced informatics techniques to pool data from 14 bacterial sepsis transcriptomic datasets from eight different countries (n = 700). SETTING: Retrospective analysis. SUBJECTS:Persons admitted to the hospital with bacterial sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A unified clustering analysis across 14 discovery datasets revealed three subtypes, which, based on functional analysis, we termed "Inflammopathic, Adaptive, and Coagulopathic." We then validated these subtypes in nine independent datasets from five different countries (n = 600). In both discovery and validation data, the Adaptive subtype is associated with a lower clinical severity and lower mortality rate, and the Coagulopathic subtype is associated with higher mortality and clinical coagulopathy. Further, these clusters are statistically associated with clusters derived by others in independent single sepsis cohorts. CONCLUSIONS: The three sepsis subtypes may represent a unifying framework for understanding the molecular heterogeneity of the sepsis syndrome. Further study could potentially enable a precision medicine approach of matching novel immunomodulatory therapies with septicpatients most likely to benefit.
Authors: Grant P Parnell; Benjamin M Tang; Marek Nalos; Nicola J Armstrong; Stephen J Huang; David R Booth; Anthony S McLean Journal: Shock Date: 2013-09 Impact factor: 3.454
Authors: Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee Journal: Am J Respir Crit Care Med Date: 2017-02-01 Impact factor: 21.405
Authors: Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405
Authors: Pranab Haldar; Ian D Pavord; Ruth H Green; Dominic E Shaw; Michael A Berry; Michael Thomas; Christopher E Brightling; Andrew J Wardlaw Journal: Am J Respir Crit Care Med Date: 2008-05-14 Impact factor: 21.405
Authors: Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins Journal: Proc Natl Acad Sci U S A Date: 2013-02-11 Impact factor: 11.205
Authors: Katie L Burnham; Emma E Davenport; Jayachandran Radhakrishnan; Peter Humburg; Anthony C Gordon; Paula Hutton; Eduardo Svoren-Jabalera; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight Journal: Am J Respir Crit Care Med Date: 2017-08-01 Impact factor: 21.405
Authors: Leonora R Slatnick; Dianne Thornhill; Sara J Deakyne Davies; James B Ford; Halden F Scott; Marilyn J Manco-Johnson; Beth Boulden Warren Journal: J Pediatr Date: 2020-06-14 Impact factor: 4.406
Authors: Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes Journal: Ann Emerg Med Date: 2020-01-23 Impact factor: 5.721
Authors: Christopher W Seymour; Jason N Kennedy; Shu Wang; Chung-Chou H Chang; Corrine F Elliott; Zhongying Xu; Scott Berry; Gilles Clermont; Gregory Cooper; Hernando Gomez; David T Huang; John A Kellum; Qi Mi; Steven M Opal; Victor Talisa; Tom van der Poll; Shyam Visweswaran; Yoram Vodovotz; Jeremy C Weiss; Donald M Yealy; Sachin Yende; Derek C Angus Journal: JAMA Date: 2019-05-28 Impact factor: 56.272
Authors: Aleksandra Leligdowicz; Lauren F Chun; Alejandra Jauregui; Kathryn Vessel; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-07-19 Impact factor: 5.464
Authors: Laura T Donlin; Sung-Ho Park; Eugenia Giannopoulou; Aleksandra Ivovic; Kyung-Hyun Park-Min; Richard M Siegel; Lionel B Ivashkiv Journal: Nat Rev Rheumatol Date: 2019-06 Impact factor: 20.543
Authors: Miguel Reyes; Michael R Filbin; Roby P Bhattacharyya; Kianna Billman; Thomas Eisenhaure; Deborah T Hung; Bruce D Levy; Rebecca M Baron; Paul C Blainey; Marcia B Goldberg; Nir Hacohen Journal: Nat Med Date: 2020-02-17 Impact factor: 53.440